ArticleOncotarget2015
PD-L1 is highly expressed in Enzalutamide resistant prostate cancer.
Jennifer L Bishop et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
154 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ArticleOncotarget2015
Jennifer L Bishop et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.